GeneDx Holdings Corp. Stock-Based Compensation
GeneDx Holdings Corp. (WGS) reported Stock-Based Compensation of $15.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-03
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $6.34M, a 18.83% decline year-over-year.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $9.00M, a 125.86% increase year-over-year.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $9.78M, a 243.76% increase year-over-year.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $10.59M, a 191.14% increase year-over-year.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for fiscal 2025 was $32.16M, a 251.96% increase from fiscal 2024.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for fiscal 2024 was $9.14M.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for fiscal 2023 was -$326.00K, a 100.78% decline from fiscal 2022.
- GeneDx Holdings Corp. share-based payment arrangement, noncash expense for fiscal 2022 was $41.98M, a 80.87% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $15.34M 10-Q · filed 2026-08-03 | $25.12M derived: sum of 3 quarters · filed 2026-08-03 | $35.70M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $9.00M 10-Q · filed 2026-05-04 | $18.78M derived: sum of 2 quarters · filed 2026-05-04 | $29.36M derived: sum of 3 quarters · filed 2026-05-04 | $37.17M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $20.37M derived: sum of 2 quarters · filed 2026-02-23 | $28.18M derived: sum of 3 quarters · filed 2026-08-03 | $32.16M 10-K · filed 2026-02-23 |
| 2025-09-30 | $10.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $18.40M derived: sum of 2 quarters · filed 2026-08-03 | $22.38M 10-Q · filed 2025-10-28 | $25.23M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $7.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $11.80M 10-Q · filed 2026-08-03 | $14.64M derived: sum of 3 quarters · filed 2026-08-03 | $18.28M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $3.98M 10-Q · filed 2026-05-04 | $6.83M derived: sum of 2 quarters · filed 2026-05-04 | $10.46M derived: sum of 3 quarters · filed 2026-05-04 | $13.57M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $6.48M derived: sum of 2 quarters · filed 2026-02-23 | $9.59M derived: sum of 3 quarters · filed 2026-02-23 | $9.14M 10-K · filed 2026-02-23 |
| 2024-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $6.74M derived: sum of 2 quarters · filed 2025-10-28 | $6.29M 10-Q · filed 2025-10-28 | $5.38M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.66M 10-Q · filed 2025-07-29 | $1.75M derived: sum of 3 quarters · filed 2026-02-23 | $2.17M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | -$451.00K 10-Q · filed 2025-04-30 | -$1.36M derived: sum of 2 quarters · filed 2026-02-23 | -$933.00K derived: sum of 3 quarters · filed 2026-02-23 | -$825.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$482.00K derived: sum of 2 quarters · filed 2026-02-23 | -$374.00K derived: sum of 3 quarters · filed 2026-02-23 | -$326.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $538.00K derived: sum of 2 quarters · filed 2024-10-29 | $586.00K 10-Q · filed 2024-10-29 | $1.01M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $156.00K 10-Q · filed 2024-07-30 | $578.00K derived: sum of 3 quarters · filed 2024-07-30 | $1.85M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $48.00K 10-Q · filed 2024-04-29 | $470.00K derived: sum of 2 quarters · filed 2024-04-29 | $1.74M derived: sum of 3 quarters · filed 2024-04-29 | $24.46M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.70M derived: sum of 2 quarters · filed 2024-02-23 | $24.42M derived: sum of 3 quarters · filed 2024-02-23 | $41.98M 10-K · filed 2024-02-23 |
| 2022-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $23.99M derived: sum of 2 quarters · filed 2023-11-03 | $41.55M 10-Q · filed 2023-11-03 | $78.52M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $22.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $40.28M 10-Q · filed 2023-08-08 | $77.25M derived: sum of 3 quarters · filed 2023-08-08 | $95.26M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $17.56M 10-Q · filed 2023-05-09 | $54.53M derived: sum of 2 quarters · filed 2023-05-09 | $72.54M derived: sum of 3 quarters · filed 2023-05-09 | $72.02M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $36.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $54.98M derived: sum of 2 quarters · filed 2023-03-16 | $54.46M derived: sum of 3 quarters · filed 2023-03-16 | $219.42M 10-K · filed 2023-03-16 |
| 2021-09-30 | $18.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $17.49M derived: sum of 2 quarters · filed 2022-11-14 | $182.45M 10-Q · filed 2022-11-14 | $272.61M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | -$519.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $164.44M 10-Q · filed 2022-08-15 | $254.60M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $164.96M 10-Q · filed 2022-05-12 | $255.12M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $90.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $120.23M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $30.07M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $5.48M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |